GNI GROUP LTD. · 株式会社ジーエヌアイグループ
Last · Tokyo¥2931.00+59.00 (+2.05%)stale · yahoo · 150h ago
MA10MA20MA50
Market cap¥192.9B65.8M sh
P/E · TTM-29.8fwd 15.2 · eps -98.51 · loss
Beta1.23vs S&P 500
Div yield—annual · TTM
52w range
¥2112.00¥3740.00
Volume123.0Ksession
Issuer
Legal nameGNI GROUP LTD. · 株式会社ジーエヌアイグループ
HQJapan (JP)
ListingJP 2160
ISINJP3386370005 +2
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyJPY
Entity registrylei:5299005KSTCN0WVJMQ52
Org IDE05712
Websitewww.gnipharma.com
Employees990
AddressGNI Group Ltd. Nihonbashi-Honcho YS Building, 3/F 103-0023, Tokyo +81 3 6214 3600
| Revenue | ¥26.8B |
|---|---|
| Operating income | ¥-3.5B |
| Net income | ¥-4.2B |
| Free cash flow | ¥-2.7B |
| Operating margin | -12.9% |
| Net margin | -15.8% |
| Return on equity | -8.4% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
ANNUAL · 2026-03-27
From latest ANNUAL · 2026-03-27
- Operating Cf Burn
Red flags
- Operating Cf Burn — Negative operating cash flow
Upcoming earnings
FRI.13NOV
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Press & signals
- GlobeNewswire
GNI Group Completes Acquisition of AYUMI Pharmaceutical
Documents
FormReporting forFiledFlags
Showing 5 of 126 filings